TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs2764894
log Bayes Factor = <0.0001
Chromosome 1   position 59,342,665  (GRCh37) Explore rs2764894 on Ensembl!
Variant rs2764894 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
C25.9 Pancreas, unspecified
0.000 0.927 0.073
C25 Malignant neoplasm of pancreas
0.000 0.947 0.053
C25.0 Head of pancreas
0.000 0.954 0.046
C25.2 Tail of pancreas
0.000 0.954 0.046
C25.1 Body of pancreas
0.000 0.956 0.044
C25.7 Other parts of pancreas
0.000 0.963 0.037
C25.3 Pancreatic duct
0.000 0.963 0.037
C25.4 Endocrine pancreas
0.000 0.964 0.036
C25.8 Overlapping lesion of pancreas
0.000 0.967 0.033
S22.30 Fracture of rib (closed)
0.028 0.972 0.000
Y45.1 Salicylates
0.000 0.980 0.020
L40.9 Psoriasis, unspecified
0.000 0.980 0.020
L40 Psoriasis
0.000 0.981 0.019
L40.0 Psoriasis vulgaris
0.000 0.982 0.018
I12.9 Hypertensive renal disease without renal failure
0.000 0.982 0.018
Y45 Analgesics, antipyretics and anti-inflammatory drugs
0.000 0.982 0.018
L40.5 Arthropathic psoriasis
0.000 0.984 0.016
C15.9 Oesophagus, unspecified
0.000 0.984 0.016
Y45.5 4-Aminophenol derivatives
0.000 0.985 0.015
Y45.2 Propionic acid derivatives
0.000 0.985 0.015
C15 Malignant neoplasm of oesophagus
0.000 0.985 0.015
C15.5 Lower third of oesophagus
0.000 0.985 0.015
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.000 0.985 0.015
L40.3 Pustulosis palmaris et plantaris
0.000 0.986 0.014
S22.3 Fracture of rib
0.014 0.986 0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.000 0.986 0.014
Y51 Drugs primarily affecting the autonomic nervous system
0.000 0.986 0.014
L40.2 Acrodermatitis continua
0.000 0.986 0.014
Y52 Agents primarily affecting the cardiovascular system
0.000 0.986 0.014
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified
0.000 0.987 0.013
L40.4 Guttate psoriasis
0.000 0.987 0.013
Y44 Agents primarily affecting blood constituents
0.000 0.987 0.013
L40.1 Generalised pustular psoriasis
0.000 0.987 0.013
Y45.4 Antirheumatics
0.000 0.987 0.013
Y49 Psychotropic drugs, not elsewhere classified
0.000 0.987 0.013
Y54.5 Other diuretics
0.000 0.987 0.013
L40.8 Other psoriasis
0.000 0.987 0.013
Y54.3 Benzothiadiazine derivatives
0.000 0.988 0.012
Y49.5 Other antipsychotics and neuroleptics
0.000 0.988 0.012
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.988 0.012
Y41 Other systemic anti-infectives and antiparasitics
0.000 0.988 0.012
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified
0.000 0.988 0.012
C15.3 Upper third of oesophagus
0.000 0.988 0.012
Y52.4 Angiotensin-converting-enzyme inhibitors
0.000 0.988 0.012
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.000 0.988 0.012
Y45.8 Other analgesics and antipyretics
0.000 0.988 0.012
Y52.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.988 0.012
Y44.2 Anticoagulants
0.000 0.988 0.012
I12 Hypertensive renal disease
0.000 0.988 0.012
C15.0 Cervical part of oesophagus
0.000 0.988 0.011
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
0.000 0.988 0.011
Y41.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.988 0.011
Y47 Sedatives, hypnotics and antianxiety drugs
0.000 0.988 0.011
L40-L45 Papulosquamous disorders
0.000 0.988 0.011
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]
0.000 0.989 0.011
L42 Pityriasis rosea
0.000 0.989 0.011
C15.8 Overlapping lesion of oesophagus
0.000 0.989 0.011
C15.2 Abdominal part of oesophagus
0.000 0.989 0.011
Y54.8 Agents affecting uric acid metabolism
0.000 0.989 0.011
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations
0.000 0.989 0.011
Y52.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.989 0.011
C15.1 Thoracic part of oesophagus
0.000 0.989 0.011
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.989 0.011
I12.0 Hypertensive renal disease with renal failure
0.000 0.989 0.011
Y50 Central nervous system stimulants, not elsewhere classified
0.000 0.989 0.011
Y52.7 Peripheral vasodilators
0.000 0.989 0.010
S22.31 Fracture of rib (open)
0.010 0.990 0.000
Y54.9 Mineral salts, not elsewhere classified
0.000 0.990 0.010
Y54.6 Electrolytic, caloric and water-balance agents
0.000 0.990 0.010
Y54.2 Carbonic-anhydrase inhibitors
0.000 0.990 0.010
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]
0.000 0.990 0.010
Y55.4 Expectorants
0.000 0.990 0.010
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.990 0.010
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.990 0.010
Y51.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.990 0.010
Y51.1 Other parasympathomimetics [cholinergics]
0.000 0.990 0.010
Y51.0 Anticholinesterase agents
0.000 0.990 0.010
Y55.6 Antiasthmatics, not elsewhere classified
0.000 0.990 0.010
Y58 Bacterial vaccines
0.000 0.990 0.010
C15.4 Middle third of oesophagus
0.000 0.990 0.010
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.990 0.010
Y44.5 Thrombolytic drugs
0.000 0.990 0.010
Y52.8 Antivaricose drugs, including sclerosing agents
0.000 0.990 0.010
Y59 Other and unspecified vaccines and biological substances
0.000 0.990 0.010
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system
0.000 0.990 0.010
Y44.9 Other and unspecified agents affecting blood constituents
0.000 0.990 0.010
Y44.7 Plasma substitutes
0.000 0.990 0.010
Y44.6 Natural blood and blood products
0.000 0.990 0.010
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations
0.000 0.990 0.010
Y52.3 Coronary vasodilators, not elsewhere classified
0.000 0.990 0.010
Y49.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.990 0.010
Y54.4 Loop [high-ceiling] diuretics
0.000 0.990 0.010
Y48 Anaesthetics and therapeutic gases
0.000 0.990 0.010
Y54.7 Agents affecting calcification
0.000 0.990 0.009
Y49.9 Psychotropic drug, unspecified
0.000 0.990 0.009
Y49.7 Psychostimulants with abuse potential
0.000 0.990 0.009
Y49.6 Psychodysleptics [hallucinogens]
0.000 0.990 0.009
Y49.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.990 0.009
Y49.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.990 0.009
Y49.0 Tricyclic and tetracyclic antidepressants
0.000 0.990 0.009
Y41.0 Sulphonamides
0.000 0.991 0.009
Y54.0 Mineralocorticoids
0.000 0.991 0.009
Y47.1 Benzodiazepines
0.000 0.991 0.009
Y52.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.991 0.009
C15-C26 Malignant neoplasms of digestive organs
0.000 0.991 0.009
Y55.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.991 0.009
Y55.5 Anticommon cold drugs
0.000 0.991 0.009
Y55.3 Antitussives
0.000 0.991 0.009
Y55.2 Other and unspecified agents primarily acting on muscles
0.000 0.991 0.009
Y55.0 Oxytocic drugs
0.000 0.991 0.009
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.991 0.009
Y41.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.991 0.009
Y41.4 Anthelminthics
0.000 0.991 0.009
Y41.3 Other antiprotozoal drugs
0.000 0.991 0.009
Y41.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.991 0.009
Y45.0 Opioids and related analgesics
0.000 0.991 0.009
C92.1 Chronic myeloid leukaemia
0.000 0.991 0.009
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified
0.000 0.991 0.009
Y40 Systemic antibiotics
0.000 0.991 0.009
Y49.2 Other and unspecified antidepressants
0.000 0.991 0.009
Y41.1 Antimycobacterial drugs
0.000 0.991 0.009
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.991 0.009
Y49.8 Other psychotropic drugs, not elsewhere classified
0.000 0.991 0.008
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.991 0.008
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified
0.000 0.991 0.008
Y47.8 Other sedatives, hypnotics and antianxiety drugs
0.000 0.991 0.008
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified
0.000 0.991 0.008
Y47.4 Bromine compounds
0.000 0.991 0.008
Y47.3 Paraldehyde
0.000 0.991 0.008
Y47.2 Chloral derivatives
0.000 0.991 0.008
Y47.0 Barbiturates, not elsewhere classified
0.000 0.991 0.008
L41 Parapsoriasis
0.000 0.991 0.008
L45 Papulosquamous disorders in diseases classified elsewhere
0.000 0.991 0.008
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.000 0.992 0.008
C24 Malignant neoplasm of other and unspecified parts of biliary tract
0.000 0.992 0.008
C16 Malignant neoplasm of stomach
0.000 0.992 0.008
Y46 Antiepileptics and anti-Parkinsonism drugs
0.000 0.992 0.008
C16.0 Cardia
0.000 0.992 0.008
Y48.2 Other and unspecified general anaesthetics
0.000 0.992 0.008
C92.0 Acute myeloid leukaemia
0.000 0.992 0.008
Y57 Other and unspecified drugs and medicaments
0.000 0.992 0.008
L44 Other papulosquamous disorders
0.000 0.992 0.008
Y52.1 Calcium-channel blockers
0.000 0.992 0.008
Y50.9 Central nervous system stimulant, unspecified
0.000 0.992 0.008
Y50.8 Other central nervous system stimulants
0.000 0.992 0.008
Y50.1 Opioid receptor antagonists
0.000 0.992 0.008
Y50.0 Analeptics
0.000 0.992 0.008
C24.0 Extrahepatic bile duct
0.000 0.992 0.008
Y50.2 Methylxanthines, not elsewhere classified
0.000 0.992 0.008
Y53 Agents primarily affecting the gastro-intestinal system
0.000 0.992 0.008
Y40.9 Systemic antibiotic, unspecified
0.000 0.992 0.008
Y43 Primarily systemic agents
0.000 0.992 0.008
V23.4 Driver injured in traffic accident
0.008 0.992 0.000
C16.2 Body of stomach
0.000 0.992 0.008
Y40.8 Other systemic antibiotics
0.000 0.992 0.008
Y41.5 Antiviral drugs
0.000 0.992 0.007
Y58.9 Other and unspecified bacterial vaccines
0.000 0.992 0.007
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component
0.000 0.992 0.007
Y58.6 Pertussis vaccine, including combinations with a pertussis component
0.000 0.992 0.007
Y58.5 Diphtheria vaccine
0.000 0.992 0.007
Y58.4 Tetanus vaccine
0.000 0.992 0.007
Y58.3 Plague vaccine
0.000 0.992 0.007
Y58.2 Cholera vaccine
0.000 0.992 0.007
Y58.1 Typhoid and paratyphoid vaccine
0.000 0.992 0.007
C23 Malignant neoplasm of gallbladder
0.000 0.992 0.008
C92 Myeloid leukaemia
0.000 0.993 0.007
Y59.9 Vaccine or biological substance, unspecified
0.000 0.993 0.007
Y59.8 Other specified vaccines and biological substances
0.000 0.993 0.007
Y59.2 Protozoal vaccines
0.000 0.993 0.007
Y59.1 Rickettsial vaccines
0.000 0.993 0.007
Y59.3 Immunoglobulin
0.000 0.993 0.007
L43 Lichen planus
0.000 0.993 0.007
Y48.5 Therapeutic gases
0.000 0.993 0.007
Y48.1 Parenteral anaesthetics
0.000 0.993 0.007
Y48.0 Inhaled anaesthetics
0.000 0.993 0.007
Y58.0 BCG vaccine
0.000 0.993 0.007
Y40.3 Macrolides
0.000 0.993 0.007
Y59.0 Viral vaccines
0.000 0.993 0.006
Y40.2 Chloramphenicol group
0.000 0.993 0.007
Y40.5 Aminoglycosides
0.000 0.993 0.007
Y46.2 Hydantoin derivatives
0.000 0.993 0.006
Y46.5 Valproic acid
0.000 0.993 0.006
C24.1 Ampulla of Vater
0.000 0.993 0.006
Y40.7 Antifungal antibiotics, systemically used
0.000 0.993 0.006
C16.6 Greater curvature of stomach, unspecified
0.000 0.994 0.006
L41.9 Parapsoriasis, unspecified
0.000 0.994 0.006
L41.8 Other parapsoriasis
0.000 0.994 0.006
L41.5 Retiform parapsoriasis
0.000 0.994 0.006
L41.4 Large plaque parapsoriasis
0.000 0.994 0.006
L41.3 Small plaque parapsoriasis
0.000 0.994 0.006
L41.2 Lymphomatoid papulosis
0.000 0.994 0.006
L41.1 Pityriasis lichenoides chronica
0.000 0.994 0.006
L41.0 Pityriasis lichenoides et varioliformis acuta
0.000 0.994 0.006
Y57.9 Drug or medicament, unspecified
0.000 0.994 0.006
Y43.4 Immunosuppressive agents
0.000 0.994 0.006
C16.8 Overlapping lesion of stomach
0.000 0.994 0.006
Y56.9 Topical agent, unspecified
0.000 0.994 0.006
Y56.8 Other topical agents
0.000 0.994 0.006
Y56.7 Dental drugs, topically applied
0.000 0.994 0.006
Y56.6 Otorhinolaryngological drugs and preparations
0.000 0.994 0.006
Y56.5 Ophthalmological drugs and preparations
0.000 0.994 0.006
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.994 0.006
Y56.2 Local astringents and local detergents
0.000 0.994 0.006
Y56.1 Antipruritics
0.000 0.994 0.006
C24.8 Overlapping lesion of biliary tract
0.000 0.994 0.006
C16.4 Pylorus
0.000 0.994 0.006
Y40.4 Tetracyclines
0.000 0.994 0.006
Y40.6 Rifamycins
0.000 0.994 0.006
Y46.8 Antispasticity drugs
0.000 0.994 0.006
Y46.3 Deoxybarbiturates
0.000 0.994 0.006
Y46.1 Oxazolidinediones
0.000 0.994 0.006
Y46.0 Succinimides
0.000 0.994 0.006
C24.9 Biliary tract, unspecified
0.000 0.994 0.006
C16.5 Lesser curvature of stomach, unspecified
0.000 0.994 0.006
Y48.3 Local anaesthetics
0.000 0.994 0.006
C16.1 Fundus of stomach
0.000 0.994 0.006
Y57.7 Vitamins, not elsewhere classified
0.000 0.994 0.006
Y57.4 Pharmaceutical excipients
0.000 0.994 0.006
Y57.3 Alcohol deterrents
0.000 0.994 0.006
Y57.2 Antidotes and chelating agents, not elsewhere classified
0.000 0.994 0.006
Y57.1 Lipotropic drugs
0.000 0.994 0.006
Y57.0 Appetite depressants [anorectics]
0.000 0.994 0.006
L44.9 Papulosquamous disorder, unspecified
0.000 0.994 0.006
L44.8 Other specified papulosquamous disorders
0.000 0.994 0.006
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]
0.000 0.994 0.006
L44.3 Lichen ruber moniliformis
0.000 0.994 0.006
L44.2 Lichen striatus
0.000 0.994 0.006
L44.1 Lichen nitidus
0.000 0.994 0.006
Y48.4 Anaesthetic, unspecified
0.000 0.994 0.006
L43.8 Other lichen planus
0.000 0.994 0.006
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.994 0.006
Y53.7 Emetics
0.000 0.994 0.006
Y53.5 Digestants
0.000 0.994 0.006
Y53.3 Saline and osmotic laxatives
0.000 0.994 0.006
Y53.2 Stimulant laxatives
0.000 0.994 0.006
Y53.0 Histamine H2-receptor antagonists
0.000 0.994 0.006
C92.7 Other myeloid leukaemia
0.000 0.994 0.006
Y43.9 Primarily systemic agent, unspecified
0.000 0.994 0.006
Y43.8 Other primarily systemic agents, not elsewhere classified
0.000 0.994 0.006
Y43.6 Enzymes, not elsewhere classified
0.000 0.994 0.006
Y43.5 Acidifying and alkalising agents
0.000 0.994 0.006
C92.4 Acute promyelocytic leukaemia
0.000 0.994 0.006
Y46.7 Anti-Parkinsonism drugs
0.000 0.994 0.005
Y56.3 Emollients, demulcents and protectants
0.000 0.994 0.005
Z13.9 Special screening examination, unspecified
0.000 0.994 0.006
Y53.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.994 0.005
L43.0 Hypertrophic lichen planus
0.000 0.994 0.006
C92.8 Acute myeloid leukaemia with multilineage dysplasia
0.000 0.994 0.005
C92.6 Acute myeloid leukaemia with 11q23-abnormality
0.000 0.994 0.005
C92.5 Acute myelomonocytic leukaemia
0.000 0.994 0.005
C92.3 Myeloid sarcoma
0.000 0.994 0.005
C92.2 Subacute myeloid leukaemia
0.000 0.994 0.005
Y53.6 Antidiarrhoeal drugs
0.000 0.994 0.005
L43.3 Subacute (active) lichen planus
0.000 0.994 0.005
L43.2 Lichenoid drug reaction
0.000 0.994 0.005
L43.1 Bullous lichen planus
0.000 0.994 0.005
Y43.2 Antineoplastic natural products
0.000 0.994 0.005
Y53.4 Other laxatives
0.000 0.995 0.005
L44.0 Pityriasis rubra pilaris
0.000 0.995 0.005
Y57.8 Other drugs and medicaments
0.000 0.995 0.005
Y43.0 Antiallergic and antiemetic drugs
0.000 0.995 0.005
C16.9 Stomach, unspecified
0.000 0.995 0.005
S51.0 Open wound of elbow
0.005 0.995 0.000
C92.9 Myeloid leukaemia, unspecified
0.000 0.995 0.005
Y40.1 Cefalosporins and other -lactam antibiotics
0.000 0.995 0.005
Y57.6 Other diagnostic agents
0.000 0.995 0.005
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.995 0.005
Y57.5 X-ray contrast media
0.000 0.995 0.005
Y46.6 Other and unspecified antiepileptics
0.000 0.995 0.004
Y46.4 Iminostilbenes
0.000 0.995 0.004
Y43.3 Other antineoplastic drugs
0.000 0.995 0.005
Y43.1 Antineoplastic antimetabolites
0.000 0.995 0.004
Y53.1 Other antacids and anti-gastric-secretion drugs
0.000 0.995 0.004
C26 Malignant neoplasm of other and ill-defined digestive organs
0.000 0.996 0.004
C22 Malignant neoplasm of liver and intrahepatic bile ducts
0.000 0.996 0.004
C16.3 Pyloric antrum
0.000 0.996 0.004
M80.90 Unspecified osteoporosis with pathological fracture (Multiple sites)
0.000 0.996 0.004
C17 Malignant neoplasm of small intestine
0.000 0.996 0.004
C21 Malignant neoplasm of anus and anal canal
0.000 0.996 0.004
S22 Fracture of rib(s), sternum and thoracic spine
0.004 0.996 0.000
O23.5 Infections of the genital tract in pregnancy
0.000 0.996 0.004
C22.1 Intrahepatic bile duct carcinoma
0.000 0.996 0.004
E34.9 Endocrine disorder, unspecified
0.004 0.996 0.000
N99.0 Postprocedural renal failure
0.000 0.996 0.004
C01 Malignant neoplasm of base of tongue
0.004 0.996 0.000
S60.9 Superficial injury of wrist and hand, unspecified
0.003 0.997 0.000
C26.8 Overlapping lesion of digestive system
0.000 0.997 0.003
C26.1 Spleen
0.000 0.997 0.003
L43.9 Lichen planus, unspecified
0.000 0.997 0.003
Y40.0 Penicillins
0.000 0.997 0.003
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified
0.000 0.997 0.003
C22.7 Other specified carcinomas of liver
0.000 0.997 0.003
C22.4 Other sarcomas of liver
0.000 0.997 0.003
C22.3 Angiosarcoma of liver
0.000 0.997 0.003
C22.2 Hepatoblastoma
0.000 0.997 0.003
V23 Motorcycle rider injured in collision with car, pick-up truck or van
0.003 0.997 0.000
S49.9 Unspecified injury of shoulder and upper arm
0.000 0.997 0.003
K09.0 Developmental odontogenic cysts
0.003 0.997 0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.997 0.003
C17.8 Overlapping lesion of small intestine
0.000 0.997 0.003
C17.3 Meckel's diverticulum
0.000 0.997 0.003
R49.0 Dysphonia
0.000 0.997 0.003
S42.30 Fracture of shaft of humerus (closed)
0.000 0.997 0.003
C21.2 Cloacogenic zone
0.000 0.997 0.003
Z93.6 Other artificial openings of urinary tract status
0.000 0.997 0.003
C26.9 Ill-defined sites within the digestive system
0.000 0.997 0.003
L02.2 Cutaneous abscess, furuncle and carbuncle of trunk
0.000 0.997 0.003
S22.9 Fracture of bony thorax, part unspecified
0.003 0.997 0.000
S22.8 Fracture of other parts of bony thorax
0.003 0.997 0.000
C17.1 Jejunum
0.000 0.997 0.003
C17.9 Small intestine, unspecified
0.000 0.997 0.003
I80.9 Phlebitis and thrombophlebitis of unspecified site
0.000 0.997 0.003
V89.2 Person injured in unspecified motor-vehicle accident, traffic
0.000 0.997 0.003
S22.5 Flail chest
0.003 0.997 0.000
S22.1 Multiple fractures of thoracic spine
0.003 0.997 0.000
A41.1 Septicaemia due to other specified staphylococcus
0.000 0.997 0.003
S22.2 Fracture of sternum
0.003 0.997 0.000
R47.8 Other and unspecified speech disturbances
0.000 0.997 0.003
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.000 0.997 0.003
V23.9 Unspecified motorcycle rider injured in traffic accident
0.002 0.997 0.000
V23.3 Person injured while boarding or alighting
0.002 0.997 0.000
V23.2 Unspecified motorcycle rider injured in nontraffic accident
0.002 0.997 0.000
V23.1 Passenger injured in nontraffic accident
0.002 0.997 0.000
V23.0 Driver injured in nontraffic accident
0.002 0.997 0.000
M72.27 Plantar fascial fibromatosis-Ankle/Foot
0.003 0.997 0.000
C21.8 Overlapping lesion of rectum, anus and anal canal
0.000 0.997 0.002
O23.4 Unspecified infection of urinary tract in pregnancy
0.000 0.997 0.003
Y42.8 Other and unspecified hormones and their synthetic substitutes
0.002 0.997 0.001
J98.4 Other disorders of lung
0.000 0.997 0.003
J69.0 Pneumonitis due to food and vomit
0.003 0.997 0.000
C21.1 Anal canal
0.000 0.997 0.002
G30.9 Alzheimer's disease, unspecified
0.000 0.997 0.002
H92.1 Otorrhoea
0.000 0.998 0.002
Y42.4 Oral contraceptives
0.000 0.998 0.002
F42.9 Obsessive-compulsive disorder, unspecified
0.002 0.998 0.000
S22.0 Fracture of thoracic vertebra
0.002 0.998 0.000
C17.0 Duodenum
0.000 0.998 0.002
Y42.2 Antithyroid drugs
0.000 0.998 0.002
C17.2 Ileum
0.000 0.998 0.002
Y42.1 Thyroid hormones and substitutes
0.000 0.998 0.002
H54.0 Blindness, both eyes
0.000 0.998 0.002
Y42.9 Other and unspecified hormone antagonists
0.000 0.998 0.002
Y60.0 During surgical operation
0.000 0.998 0.002
S22.81 Fracture of other parts of bony thorax (open)
0.002 0.998 0.000
S22.80 Fracture of other parts of bony thorax (closed)
0.002 0.998 0.000
S22.91 Fracture of bony thorax, part unspecified (open)
0.002 0.998 0.000
S22.90 Fracture of bony thorax, part unspecified (closed)
0.002 0.998 0.000
M35.0 Sicca syndrome [Sjogren]
0.002 0.998 0.000
S22.4 Multiple fractures of ribs
0.002 0.998 0.000
G47.1 Disorders of excessive somnolence [hypersomnias]
0.002 0.998 0.000
S22.51 Flail chest (open)
0.002 0.998 0.000
D32.0 Cerebral meninges
0.000 0.998 0.002
O23 Infections of genito-urinary tract in pregnancy
0.000 0.998 0.002
C10.9 Oropharynx, unspecified
0.002 0.998 0.000
C78.2 Secondary malignant neoplasm of pleura
0.000 0.998 0.002
S22.11 Multiple fractures of thoracic spine (open)
0.002 0.998 0.000
E61.1 Iron deficiency
0.000 0.998 0.002
S22.21 Fracture of sternum (open)
0.002 0.998 0.000
V23.99 Motorcycle rider injured in collision with car, pick-up truck or van, Unspecified motorcycle rider injured in traffic accident, Unspecified place
0.002 0.998 0.000
C21.0 Anus, unspecified
0.000 0.998 0.002
V23.5 Passenger injured in traffic accident
0.002 0.998 0.000
S22.50 Flail chest (closed)
0.002 0.998 0.000
D05.9 Carcinoma in situ of breast, unspecified
0.002 0.998 0.000
C10 Malignant neoplasm of oropharynx
0.002 0.998 0.000
D69.5 Secondary thrombocytopenia
0.000 0.998 0.002
S22.01 Fracture of thoracic vertebra (open)
0.002 0.998 0.000
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx
0.002 0.998 0.000
S22.10 Multiple fractures of thoracic spine (closed)
0.002 0.998 0.000
K07.3 Anomalies of tooth position
0.002 0.998 0.000
C22.9 Liver, unspecified
0.000 0.998 0.002
D69.6 Thrombocytopenia, unspecified
0.000 0.998 0.002
C04 Malignant neoplasm of floor of mouth
0.002 0.998 0.000
C12 Malignant neoplasm of pyriform sinus
0.002 0.998 0.000
S22.20 Fracture of sternum (closed)
0.002 0.998 0.000
S22.41 Multiple fractures of ribs (open)
0.002 0.998 0.000
C02.9 Tongue, unspecified
0.002 0.998 0.000
O23.3 Infections of other parts of urinary tract in pregnancy
0.000 0.998 0.002
O23.2 Infections of urethra in pregnancy
0.000 0.998 0.002
O23.1 Infections of bladder in pregnancy
0.000 0.998 0.002
C04.0 Anterior floor of mouth
0.002 0.998 0.000
L08.8 Other specified local infections of skin and subcutaneous tissue
0.000 0.998 0.002
C90.0 Multiple myeloma
0.000 0.998 0.002
D37.4 Colon
0.000 0.998 0.002
C11 Malignant neoplasm of nasopharynx
0.002 0.998 0.000
C22.0 Liver cell carcinoma
0.000 0.998 0.002
S70.9 Superficial injury of hip and thigh, unspecified
0.000 0.998 0.002
C03 Malignant neoplasm of gum
0.002 0.998 0.000
C26.0 Intestinal tract, part unspecified
0.001 0.998 0.001
D69.4 Other primary thrombocytopenia
0.000 0.998 0.002
J98.1 Pulmonary collapse
0.000 0.998 0.002
L91.8 Other hypertrophic disorders of skin
0.000 0.998 0.002
C02 Malignant neoplasm of other and unspecified parts of tongue
0.002 0.998 0.000
D69 Purpura and other haemorrhagic conditions
0.000 0.998 0.002
G58.8 Other specified mononeuropathies
0.002 0.998 0.000
Y42.0 Glucocorticoids and synthetic analogs
0.000 0.998 0.002
Z51.3 Blood transfusion without reported diagnosis
0.000 0.998 0.002
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx
0.002 0.998 0.000
M35.7 Hypermobility syndrome
0.002 0.998 0.000
S61.8 Open wound of other parts of wrist and hand
0.000 0.998 0.002
C10.8 Overlapping lesion of oropharynx
0.002 0.998 0.000
C10.4 Branchial cleft
0.002 0.998 0.000
C10.3 Posterior wall of oropharynx
0.002 0.998 0.000
C10.2 Lateral wall of oropharynx
0.002 0.998 0.000
C10.1 Anterior surface of epiglottis
0.002 0.998 0.000
C10.0 Vallecula
0.002 0.998 0.000
Z75.1 Person awaiting admission to adequate facility elsewhere
0.002 0.998 0.000
C02.2 Ventral surface of tongue
0.002 0.998 0.000
C11.9 Nasopharynx, unspecified
0.002 0.998 0.000
D69.0 Allergic purpura
0.000 0.998 0.002
T90.2 Sequelae of fracture of skull and facial bones
0.000 0.998 0.002
S49 Other and unspecified injuries of shoulder and upper arm
0.000 0.998 0.002
C02.8 Overlapping lesion of tongue
0.002 0.998 0.000
O23.0 Infections of kidney in pregnancy
0.000 0.998 0.002
T79.3 Post-traumatic wound infection, not elsewhere classified
0.002 0.998 0.000
E34 Other endocrine disorders
0.002 0.998 0.000
C30.0 Nasal cavity
0.002 0.998 0.000
C04.9 Floor of mouth, unspecified
0.002 0.998 0.000
C03.9 Gum, unspecified
0.002 0.998 0.000
K22.4 Dyskinesia of oesophagus
0.002 0.998 0.000
O23.9 Other and unspecified genito-urinary tract infection in pregnancy
0.000 0.998 0.002
S49.8 Other specified injuries of shoulder and upper arm
0.000 0.998 0.002
C04.8 Overlapping lesion of floor of mouth
0.002 0.998 0.000
C04.1 Lateral floor of mouth
0.002 0.998 0.000
J11.1 Influenza with other respiratory manifestations, virus not identified
0.000 0.998 0.002
S56.1 Injury of flexor muscle and tendon of other finger(s) at forearm level
0.000 0.998 0.002
C03.1 Lower gum
0.002 0.998 0.000
C14.0 Pharynx, unspecified
0.002 0.998 0.000
D47.1 Chronic myeloproliferative disease
0.000 0.998 0.002
C08 Malignant neoplasm of other and unspecified major salivary glands
0.002 0.998 0.000
Z22.5 Carrier of viral hepatitis
0.000 0.998 0.002
C03.0 Upper gum
0.001 0.998 0.000
C11.8 Overlapping lesion of nasopharynx
0.001 0.998 0.000
C11.3 Anterior wall of nasopharynx
0.001 0.998 0.000
C11.2 Lateral wall of nasopharynx
0.001 0.998 0.000
C11.1 Posterior wall of nasopharynx
0.001 0.998 0.000
C11.0 Superior wall of nasopharynx
0.001 0.998 0.000
E34.0 Carcinoid syndrome
0.002 0.998 0.000
O20.9 Haemorrhage in early pregnancy, unspecified
0.000 0.998 0.002
M24.86 Other specific joint derangements, not elsewhere classified (Lower leg)
0.002 0.998 0.000
B37.8 Candidiasis of other sites
0.002 0.998 0.000
C02.3 Anterior two-thirds of tongue, part unspecified
0.001 0.998 0.000
C02.0 Dorsal surface of tongue
0.001 0.998 0.000
C14.8 Overlapping lesion of lip, oral cavity and pharynx
0.001 0.998 0.000
C14.2 Waldeyer's ring
0.001 0.998 0.000
D69.8 Other specified haemorrhagic conditions
0.000 0.998 0.001
C13 Malignant neoplasm of hypopharynx
0.001 0.998 0.000
D69.9 Haemorrhagic condition, unspecified
0.000 0.998 0.002
R06.8 Other and unspecified abnormalities of breathing
0.000 0.998 0.002
M88.90 Paget's disease of bone, unspecified (Multiple sites)
0.002 0.998 0.000
C00 Malignant neoplasm of lip
0.001 0.998 0.000
C90.1 Plasma cell leukaemia
0.000 0.998 0.001
D69.1 Qualitative platelet defects
0.000 0.998 0.001
M88.99 Paget's disease of bone, unspecified (Site unspecified)
0.001 0.998 0.000
E34.5 Androgen resistance syndrome
0.001 0.998 0.000
E34.4 Constitutional tall stature
0.001 0.998 0.000
E34.2 Ectopic hormone secretion, not elsewhere classified
0.001 0.998 0.000
E34.1 Other hypersecretion of intestinal hormones
0.001 0.998 0.000
S49.7 Multiple injuries of shoulder and upper arm
0.000 0.998 0.001
S22.00 Fracture of thoracic vertebra (closed)
0.001 0.998 0.000
K80.0 Calculus of gallbladder with acute cholecystitis
0.002 0.998 0.000
M77.02 Medial epicondylitis (Upper arm)
0.000 0.998 0.001
C08.9 Major salivary gland, unspecified
0.001 0.998 0.000
C76.0 Head, face and neck
0.001 0.998 0.000
E34.3 Short stature, not elsewhere classified
0.001 0.998 0.000
I85.0 Oesophageal varices with bleeding
0.000 0.998 0.001
N99.5 Malfunction of external stoma of urinary tract
0.000 0.998 0.001
C07 Malignant neoplasm of parotid gland
0.001 0.998 0.000
C05 Malignant neoplasm of palate
0.001 0.999 0.000
M89.55 Osteolysis (Pelvic region and thigh)
0.000 0.999 0.001
C08.8 Overlapping lesion of major salivary glands
0.001 0.999 0.000
C08.1 Sublingual gland
0.001 0.999 0.000
D39.1 Ovary
0.001 0.999 0.000
E34.8 Other specified endocrine disorders
0.001 0.999 0.000
I67.8 Other specified cerebrovascular diseases
0.000 0.999 0.001
N34.3 Urethral syndrome, unspecified
0.001 0.999 0.000
T84.7 Infection and inflammatory reaction due to other internal orthopaedic prosthetic devices, implants and grafts
0.001 0.999 0.000
C00.1 External lower lip
0.001 0.999 0.000
N99.8 Other postprocedural disorders of genito-urinary system
0.001 0.999 0.000
N99.2 Postprocedural adhesions of vagina
0.000 0.999 0.001
R46.2 Strange and inexplicable behaviour
0.001 0.999 0.000
M19.95 Arthrosis, unspecified (Pelvic region and thigh)
0.000 0.999 0.001
K61.1 Rectal abscess
0.001 0.999 0.000
M72.2 Plantar fascial fibromatosis
0.001 0.999 0.000
V89 Motor- or nonmotor-vehicle accident, type of vehicle unspecified
0.000 0.999 0.001
C13.8 Overlapping lesion of hypopharynx
0.001 0.999 0.000
C13.2 Posterior wall of hypopharynx
0.001 0.999 0.000
C13.1 Aryepiglottic fold, hypopharyngeal aspect
0.001 0.999 0.000
K09.2 Other cysts of jaw
0.001 0.999 0.000
M88.9 Paget's disease of bone, unspecified
0.001 0.999 0.000
C00.8 Overlapping lesion of lip
0.001 0.999 0.000
C00.6 Commissure of lip
0.001 0.999 0.000
C00.5 Lip, unspecified, inner aspect
0.001 0.999 0.000
C00.4 Lower lip, inner aspect
0.001 0.999 0.000
C00.3 Upper lip, inner aspect
0.001 0.999 0.000
C00.2 External lip, unspecified
0.001 0.999 0.000
C13.9 Hypopharynx, unspecified
0.001 0.999 0.000
C06 Malignant neoplasm of other and unspecified parts of mouth
0.001 0.999 0.000
C90 Multiple myeloma and malignant plasma cell neoplasms
0.000 0.999 0.001
K09 Cysts of oral region, not elsewhere classified
0.001 0.999 0.000
M88.95 Paget's disease of bone, unspecified (Pelvic region and thigh)
0.001 0.999 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.